UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · IEX Real-Time Price · USD
15.79
-0.85 (-5.11%)
At close: Jul 19, 2024, 12:00 AM
16.25
+0.46 (2.91%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
UroGen Pharma Employees
As of December 31, 2023, UroGen Pharma had 201 total employees, including 198 full-time and 3 part-time employees. The number of employees increased by 1 or 0.50% compared to the previous year.
Employees
201
Change (1Y)
1
Growth (1Y)
0.50%
Revenue / Employee
$419,413
Profits / Employee
-$518,990
Market Cap
650.07M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Aveanna Healthcare Holdings | 33,500 |
Fulgent Genetics | 1,184 |
Definitive Healthcare | 830 |
Exscientia | 483 |
Phathom Pharmaceuticals | 452 |
Prime Medicine | 234 |
Arcturus Therapeutics Holdings | 180 |
Acelyrin | 135 |
URGN News
- 4 weeks ago - UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants - Business Wire
- 4 weeks ago - UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewsWire
- 5 weeks ago - Uber Advertising Announces Exclusive Partnership with T-Mobile Advertising Solutions - Business Wire
- 5 weeks ago - AscellaHealth Chairman and President Bill Oldham Named 2024 Philadelphia Titan 100 - Business Wire
- 5 weeks ago - UroGen Announces Unprecedented 82.3% Duration of Response at 12 Months in the ENVISION Trial Investigating UGN-102 as Potentially the First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC - Business Wire
- 6 weeks ago - UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 weeks ago - UroGen Pharma to Host UGN-102 Virtual Data Event on June 13, 2024 - Business Wire
- 6 weeks ago - UroGen Pharma to Present at the 45th Annual Goldman Sachs Global Healthcare Conference - Business Wire